MWNA
MDGL icon

Marshall Wace North America’s Madrigal Pharmaceuticals MDGL Stock Holding History

Marshall Wace North America’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$501K Sell
6,274
-89,106
-93% -$7.7M ﹤0.01% 1125
2021
Q2 		$9.29M Buy
+95,380
New +$11.3M 0.04% 390
2020
Q2 		– Sell
-154
Closed -$10K – 1340
2020
Q1 		$10K Buy
+154
New +$12.8K ﹤0.01% 1162
2019
Q2 		– Sell
-141,301
Closed -$17.7M – 1413
2019
Q1 		$17.7M Buy
+141,301
New +$17.6M 0.13% 157
2018
Q3 		– Sell
-34,985
Closed -$9.79M – 1186
2018
Q2 		$9.79M Buy
+34,985
New +$6.14M 0.06% 341
2018
Q1 		– Sell
-45,785
Closed -$4.2M – 1584
2017
Q4 		$4.2M Buy
+45,785
New +$2.62M 0.02% 634

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return